• <tr id="yyy80"></tr>
  • <sup id="yyy80"></sup>
  • <tfoot id="yyy80"><noscript id="yyy80"></noscript></tfoot>
  • 99热精品在线国产_美女午夜性视频免费_国产精品国产高清国产av_av欧美777_自拍偷自拍亚洲精品老妇_亚洲熟女精品中文字幕_www日本黄色视频网_国产精品野战在线观看 ?

    Mucosal-associated invariant T cells in hepatitis B virus-related liver failure

    2020-09-23 10:05:32HongXueHanLiLinLingJuXuDongHanTiaoChunChengXiLuoLinChenJianGuoShaoYongJunSheZhaoLianBian
    World Journal of Gastroenterology 2020年31期

    Hong Xue, Han Li, Lin-Ling Ju, Xu-Dong Han, Tiao-Chun Cheng, Xi Luo, Lin Chen, Jian-Guo Shao, Yong-Jun She, Zhao-Lian Bian

    Abstract

    Key words: Mucosal-associated invariant T cells; Chronic hepatitis B; Liver failure; Prognosis; Hepatitis B virus

    INTRODUCTION

    Liver failure is a life-threatening clinical syndrome caused by multiple factors, leading to severe impairment or decompensation of synthesis, detoxification, metabolism and biotransformation, mainly presenting a group of clinical manifestations such as jaundice, coagulopathy, hepatorenal syndrome, hepatic encephalopathy and ascites[1]. Liver failure is a devastating disease with high morbidity and mortality. In China, the main cause of liver failure is hepatitis B virus (HBV) infection[2]. It develops rapidly and has extremely poor prognosis[3], so judging the severity and predicting the prognosis of liver failure are important.

    Although there are various indicators or scoring systems for assessing the severity and prognosis in patients with liver failure, such as alanine aminotransferase, aspartate transaminase, prothrombin activity (PTA), model for end-stage liver disease (MELD) score and MELD-sodium (MELD-Na) score, these conventional scoring systems do not include extrahepatic organ failure and systemic inflammation, which limits their prognostic accuracy in liver failure. Because of the absence of gold standard markers for prognosis of liver failure[4], it is important to find additional reliable markers for predicting prognosis, enabling patients with poor prognosis to receive liver transplantation earlier to improve survival.

    Mucosal-associated invariant T (MAIT) cells, the most abundant T cell subset that responds to bacteria in humans, are characterized by the invariant T-cell receptor (TCR) chain, Vα7.2-Jα33, and show high expression of the natural killer cell marker CD161. MAIT cells are found throughout the body, especially in human blood and liver. MAIT cells mediate protective immunity against infection and are increasingly being recognized for their importance in microbial immunity. As one of the largest T cell populations in the human liver, MAIT cells act as a “firewall” and play an important role in the front line of defense in the liver. MAIT cells are involved in the development of various liver diseases[5]. They can be activated in an antigen- and cytokine-dependent manner in chronic inflammatory liver disease[6]. Recent studies have reported that MAIT cells in blood and liver in patients with chronic liver inflammatory disease, including alcoholic or nonalcoholic fatty liver disease, cirrhosis, autoimmune liver disease and chronic hepatitis C and D[7-9]are decreased dramatically, but the phenotype of MAIT cells is more activated or shows functional impairment in different types of liver disease. However, circulating MAIT cells are not reversed after direct-acting-antiviral-mediated clearance of hepatitis C virus (HCV)[10]. Further studies explored the mechanism of MAIT cell involvement in liver inflammatory disease, including promoting liver inflammation and fibrosis dependent on monocytederived macrophages, maintaining intestinal mucosal permeability[11]and reacting with biliary epithelium and liver B cells[12]. From previous studies, tumor-infiltrating MAIT cells are a prognostic factor for hepatocellular carcinoma[13]and colorectal cancer[14]. Circulating MAIT cells are also a biomarker for response to standard treatment in primary biliary cholangitis[15]and immune thrombocytopenia[16]and prognosis in cervical cancer[17].

    There are various reports about the frequency of circulating MAIT cells in patients with HBV infection. Yong and colleagues found that frequency of MAIT cells was decreased, presenting dysfunction in chronic hepatitis B (CHB) infection[18]. Boeijen et al[12]reported that MAIT cells were more activated and could be reversed by antiviral therapy, but the frequency of circulating MAIT cells was not decreased in CHB infection. In acute liver failure, it was reported that hepatic MAIT cells accumulated in the parenchyma, but the circulating MAIT cells were not detected and the etiology of liver failure was not revealed[19]. In China, the hepatitis B infection is the major cause of liver failure and T-cell-mediated immune injury plays a critical role in the pathogenesis of HBV-related liver failure. In this paper, we evaluated the change of circulating MAIT cells and its prognostic value in patients with HBV-related liver failure and explored the possible mechanism.

    MATERIALS AND METHODS

    Patient data

    A total of 173 participants were enrolled, including 40 healthy controls, 48 CHB patients and 85 liver failure patients. We excluded 30 non-HBV related liver failure patients and enrolled 55 HBV related liver failure patients (Figure 1). Liver failure was diagnosed and treated according to the Guidelines in China[20]. CHB patients (n= 48) were diagnosed according to the American Association for the Study of Liver Disease 2018 guidelines for hepatitis B[21]. HBV-related liver failure (n= 55) was defined as liver failure accompanied with HBV activity, which was considered as HBV-DNA positive, and without other causes of liver failure. None of the patients in the CHB and HBVrelated liver failure groups received any antiviral therapy before the study, or antiviral drugs were discontinued for > 6 mo before the study. The research process is shown in a flow chart (Figure 1), and the demographic and clinical characteristics of the participants are presented in Table 1. This study was approved by the Ethical Committee of Nantong Third People’s Hospital, Nantong University, and patients gave signed informed consent.

    Peripheral blood mononuclear cells isolation

    Peripheral blood mononuclear cells (PBMCs) were isolated by density centrifugation with GE Healthcare Ficoll-Paque PLUS Media (Thermo Scientific, Rosemont, IL, United States) as our previous study described[22]. Five milliliters of peripheral blood was centrifuged for 10 min at 300 ×gat 20 °C. The buffy coat interphase layer wascollected and then placed in a new 1.5-mL centrifuge tube. The buffy coat was mixed with an equal volume of phosphate-buffered saline. Then, 3 mL Ficoll was placed in a 15-mL centrifuge tube; the diluted buffy coat was layered on top of it; and the tube was centrifuged for 30 min at 400 ×gwith no break at room temperature. The PBMC layer was transferred and washed by phosphate-buffered saline. PBMCs were collected after centrifugation for 10 min at 300 ×gand stored in fetal bovine serum (Cell Sciences, Canton, MA, United States) with 10% dimethyl sulfoxide (Beyotime Biotechnology, Shanghai, China) in liquid nitrogen for further analysis.

    Table 1 Characteristics of healthy controls and chronic hepatitis B and hepatitis B virus-related liver failure patients

    Flow cytometry

    PBMCs were stained with combinations of the following antibodies: anti-TCRVα7.2-phycoerythrin (PE; BD Biosciences, Franklin Lakes, NJ, United States), anti-CD161-allophycocyanin (APC; BD Biosciences) and anti-CD3-fluorescein isothiocyanate (FITC; BD Biosciences). Flow cytometry was performed using FACS Calibur (BD Biosciences). Data were analyzed using FlowJo software (Tree Star, San Carlos, CA, United States).

    Plasma cytokine detection

    Interleukin (IL)-7, IL-12p70, IL-18 and interferon (IFN)-α were measured using the Human Magnetic Luminex Assay Kit (R&D Systems, Minneapolis, MN, United States) in human plasma samples. The results were read and analyzed on Luminex MAGPIX Instrument System (Luminex, Austin, TX, United States).

    Statistical analysis

    Figure 1 Flow chart for patient enrollment and analysis. Diagram showing the general process from enrolling patients to the final analysis. CHB: Chronic hepatitis B; HBV: Hepatitis B virus.

    All data are presented as mean ± standard deviation. Analysis in patients before and after therapy was done by pairedttest. One-way analysis of variance was used to analyze differences between more than two groups. The comparison of two groups was carried out byttest. Statistical evaluations were conducted with GraphPad Prism software version 8.0 (La Jolla, CA, United States), andP< 0.05 was considered statistically significant.

    RESULTS

    Characteristics of healthy controls and patients with CHB and HBV-related liver failure

    The detailed clinical characteristics of the participants, including healthy controls (HCs) (n= 40), patients with CHB (n= 48) and patients with HBV-related liver failure (n= 55), are presented in Table 1. There were no differences in age and gender between patients with CHB, patients with HBV-related liver failure and HCs. The levels of alanine aminotransferase (HBV-related liver failurevsHC: 549.60 ± 686.13vs16.55 ± 5.43,P< 0.0001; HBV-related liver failurevsCHB: 549.60 ± 686.13vs327.52 ± 312.57,P< 0.05), aspartate transaminase (HBV-related liver failurevsHC: 487.55 ± 571.49vs22.95 ± 5.70,P< 0.0001; HBV-related liver failurevsCHB: 487.55 ± 571.49vs176.58 ± 208.19,P< 0.001) and total bilirubin (HBV-related liver failurevsHC: 302.52 ± 144.84vs12.48 ± 3.23,P< 0.0001; HBV-related liver failurevsCHB: 302.52 ± 144.84vs25.65 ± 43.43,P< 0.0001) were dramatically increased in HBV-related liver failure group compared to HCs and CHB group. The levels of albumin (HBV-related liver failurevsHC: 31.01 ± 4.06vs42.98 ± 2.32,P< 0.0001; HBV-related liver failurevsCHB: 31.01 ± 4.06vs42.36 ± 3.99,P< 0.0001) and blood platelets (HBV-related liver failurevsHC: 97.96 ± 52.06vs194.68 ± 41.53,P< 0.0001; HBV-related liver failurevsCHB: 97.96 ± 52.06vs157.52 ± 67.53,P< 0.0001) were significantly decreased in HBV-related liver failure group compared to HCs and CHB group (Table 1).

    Circulating MAIT cells were dramatically decreased in HBV-related liver failure

    Circulating MAIT cells were defined as CD3+CD161+TCR Vα7.2+. The strategy for flow cytometry of MAIT cells is illustrated in Figure 2A. We counted the percentage of circulating MAIT cells in CD3+T cells and the number of circulating MAIT cells in 106PBMCs in patients with HBV-related liver failure, patients with CHB and HCs. The percentage and number of circulating MAIT cells in HBV-related liver failure patients (percentage: 2.00 ± 1.22vs5.19 ± 1.27%,P< 0.0001; number: 5.47 ± 4.93vs84.43 ± 19.59,P< 0.0001) and CHB (percentage: 3.59 ± 0.87vs5.19 ± 1.27%,P< 0.0001; number: 48.26 ± 15.45vs84.43 ± 19.59,P< 0.0001) were significantly lower than in HCs. Circulating MAIT cells exhibited a significant decrease in HBV-related liver failure patients compared with CHB patients (percentage: 2.00 ± 1.22vs3.59 ± 0.87%,P< 0.0001; number: 5.47 ± 4.93vs48.26 ± 15.45,P< 0.0001) (Figure 2B and C).

    Quantity of circulating MAIT cells was associated with severity in HBV-related liver failure patients

    Patients with HBV-related liver failure were divided into two groups according to the level of PTA: Early stage (n= 28) and middle/late stage (n= 27). The percentage and number of circulating MAIT cells were analyzed. A significant reduction in percentage (Figure 3A) and number (Figure 3B) of MAIT cells was found in patients with middle/late-stage disease compared with early stage. We analyzed the correlation between MAIT cells and parameters in Table 1, and data showed that PTA was not associated with percentage of MAIT cells (Figure 3C) but correlated with MAIT cell counts (P= 0.0321) (Figure 3D). Other parameters were not associated with the percentage or number of circulating MAIT cells in HBV-related liver failure (data not shown).

    Partial recovery of circulating MAIT cells in surviving HBV-related liver failure patients

    We collected PBMCs from 18 patients before and after therapy, including 13 surviving patients and five patients who died or received liver transplantation. The indicated time for post-therapy was defined as the endpoint of conservative treatment in patients who were cured, died or received liver transplantation. We analyzed the variation in percentage and number of circulating MAIT cells in these patients. In the survival group (n= 13), circulating MAIT cells were partially recovered after disease improvement not only in percentage (4.01 ± 1.21vs2.04 ± 0.95%,P< 0.0001) (Figure 4A), but also in cell count (17.24 ± 8.56vs7.41 ± 4.99,P< 0.0001) (Figure 4B) and they were still lower than in HCs, especially MAIT cell count (Figure 4A and B). However, the level of circulating MAIT cells showed no difference in before and after conservative treatment among those who died and received liver transplantation (n= 5) (Figure 4C and D).

    Lower circulating MAIT cells indicated poor prognosis in HBV-related liver failure

    Based on the outcome, we divided the HBV-related liver failure patients into the survival group (n= 32) and died/liver transplanted group (n= 23). Comparison of MAIT cells between them showed that the proportion (2.29 ± 1.01vs1.58 ± 1.38%,P< 0.05) (Figure 5A) and number of circulating MAIT cells (7.30 ± 5.70vs2.94 ± 1.47,P< 0.001) (Figure 5B) were significantly higher in the survival group than the died/LT group. We followed up the 55 HBV-related liver failure patients for 2-90 d, then the patients were divided into two groups, low expression (n= 27) and high expression (n= 28) of MAIT cells based on median proportion or cell counts of circulating MAIT cells. The Kaplan–Meier curve showed that lower expression of circulating MAIT cells (both percentage and cell count) predicted poor overall survival in HBV-related liver failure patients (P< 0.01) (Figure 5C and D). We compared the prognostic value of MELD score with MAIT cells (proportion and counts) and showed using receiver operating characteristic curve data that the proportion of MAIT cells can better predict the prognosis of HBV-related liver failure patients than MELD score and MAIT cell counts (Figure 6).

    Figure 2 Circulating mucosal-associated invariant T cells were dramatically decreased in hepatitis B virus-related liver failure. A: The strategy for flow cytometry of mucosal-associated invariant T (MAIT) cells; B: The percentage of circulating MAIT cells in healthy controls (HC, n = 40), chronic hepatitis B (CHB, n = 48) patients and hepatitis B virus (HBV)-related liver failure (LF) patients (n = 55); C: Circulating MAIT cell count in 106 peripheral blood mononuclear cells in HCs and CHB and HBV-related liver failure patients. bP < 0.0001.

    Plasma levels of IL-12 and IL-18 were increased in patients with HBV-related liver failure

    It is well recognized that MAIT cells can be activated and exhausted by inflammatory cytokines, including IL-12, IL-18, IL-7 and IFN-α[23,24]. To explore the possible mechanism of decreased circulating MAIT cells in HBV-related liver failure, we detected these inflammatory cytokines in the plasma of HBV-related liver failure patients (n= 46) and HCs (n= 40). The level of IL-12 (20.26 ± 5.42 pg/mLvs17.76 ± 2.79 pg/mL,P= 0.01) and IL-18 (1470.05 ± 1525.38 pg/mLvs362.99 ± 109.64 pg/mL,P< 0.0001) were increased in HBV-related liver failure patients compared to HCs (Figure 7A and B). However, there was no difference in IL-7 and IFN-α between the two groups (Figure 7C and D). These data indicated that IL-12 and IL-18 contributed to the depletion of circulating MAIT cells in HBV-related liver failure patients.

    Figure 3 Quantity of circulating mucosal-associated invariant T cells was associated with severity of hepatitis B virus-related liver failure. A, B: The percentage (A) and number (B) of circulating mucosal-associated invariant T (MAIT) cells in early- (n = 28) and middle/late-stage (n = 27) hepatitis B virus (HBV)-related liver failure; C, D: Correlation between prothrombin activity (PTA) and percentage (C) or number (D) of circulating MAIT cells in patients with HBV-related liver failure. aP < 0.05, bP < 0.01. PBMC: Peripheral blood mononuclear cell. NS: No significance.

    DISCUSSION

    In previous studies, MAIT cells were reported in multiple tissues, including liver, lung, pancreas, female genital mucosa, spleen and lymph nodes[25]. They represent about 6% of all CD3+T cells in human blood and up to 20% in the lungs. More importantly, MAIT cells account for up to 40% of T cells in the liver[26], which indicates that they play a critical role in liver disease. MAIT cells are involved in many types of immune disorders, including viral[27]and bacterial[28]infections. From further study, we know that MAIT cells recognize microbial metabolites and rapidly respond to pathogens, release cytokines, lyse target cells and promote inflammatory response, including in infectious and noninfectious inflammatory diseases, by secreting Th1 and Th17 cytokines. MAIT cells also play a critical role in liver diseases by promoting hepatitis and fibrosis, maintaining intestinal permeability and responding to biliary epithelium cells and liver B cells. MAIT cells were reported to be activated in patients with cirrhosis and displayed a proinflammatory profile. The profibrogenic functions of MAIT cells suggested that targeting MAIT cells may constitute an attractive antifibrogenic strategy during chronic liver injury. In addition, MAIT cells have antibacterial potency and play a key role as biliary firewall protecting the epithelial lining from translocated bacteria. In patients with alcoholic liver disease, the antibacterial potency of MAIT cells are impaired as a consequence of contact with microbial products and microbiota, which results in susceptibility to infection.

    Figure 4 Partial recovery of circulating mucosal-associated invariant T cells in survived hepatitis B virus-related liver failure patients. A, B: The percentage (A) and count (B) of circulating mucosal-associated invariant T (MAIT) cells before and after treatment of surviving patients (n = 13) with hepatitis B virus (HBV)-related liver failure, and in healthy controls (HC) (n = 40); C, D: The percentage (C) and number (D) of MAIT cells in patients (n = 5) who died or underwent liver transplantation in HBV-related liver failure before and after conservative treatment. bP < 0.01, dP < 0.0001. NS: No significance; PBMC: Peripheral blood mononuclear cell.

    Figure 5 Lower count of circulating mucosal-associated invariant T cells indicated poor prognosis in hepatitis B virus-related liver failure. A, B: The proportion (A) and number (B) of circulating mucosal-associated invariant T (MAIT) cells in surviving (n = 32) and deceased/liver transplanted (LT) (n = 23) patients with hepatitis B virus (HBV)-related liver failure; C, D: The Kaplan–Meier curve of HBV-related liver failure patients with low (n = 27) and high (n = 28) expression of MAIT cells in percentage (C) and count (D). aP < 0.05, cP < 0.001. PBMC: Peripheral blood mononuclear cell.

    The liver is an important immune organ in humans, with unique immune cells. MAIT cells are located around the bile ducts in the portal tracts and can exert antibacterial and antiviral effects. Hegdeet al[7]found that circulating MAIT cells were reduced in patients with alcoholic or nonalcoholic fatty liver disease-related cirrhosis. Yonget al[29]demonstrated that peripheral MAIT cells were significantly decreased in chronic HBV-infected patients. In line with the results above, we discovered that circulating MAIT cells were significantly reduced in patients with CHB. Additionally, we found that circulating MAIT cells were dramatically decreased in HBV-related liver failure compared with CHB. These findings may indicate that HBV-related liver failure may represent a more advanced and aggressive state of inflammatory cascade that may be incriminated in the more depressive effect on the status of circulating MAIT cells. However, Boeijenet al[12]suggested that MAIT cells were not depleted in chronic HBV-infected patients but more activated. The reason for this difference may include the number of patients and the different stages of the disease. In recent research, Niehauset al[30]demonstrated enrichment of MAIT cells in the peritoneal cavity, but circulating MAIT cells were dramatically decreased in patients with cirrhosis. Also, they reported that MAIT cells in ascites were almost intact and highly activated. This was because ascites in patients with decompensated cirrhosis represents a special immune environment, which is different from peripheral blood, resulting in different observed cell phenotypes and functions.

    Immune responses play a crucial role in the pathogenesis of liver failure, and T-cellmediated immune responses play a critical role in the pathogenesis of HBV-related acute-on-chronic liver failure (ACLF). The enrichment of MAIT cells in the liver and its anatomical location close to the biliary tract suggest that MAIT cells play an important role in liver immune defense and possibly HBV-related liver failure. A recent study[31]suggested that T-cell-mediated immune response plays a vital role in acute HBV infection and the pathogenesis of HBV-related ACLF, which suggests that T-cell responses play a crucial role in virus control and immune-mediated liver damage. Another recent study[32]showed that chronic HBV and HCV infections always lead to T-cell depletion or dysfunction, which results in immune tolerance and viral persistence. The pathogenesis of ACLF is also a dysfunctional immune response caused by systemic inflammation and increased immune cell paralysis.

    Figure 6 The prognostic value of model for end-stage liver disease score, mucosal-associated invariant T cell counts and percentage of mucosal-associated invariant T cells in patients with hepatitis B virus-related liver failure. The receiver characteristic operator curve of model for end-stage liver disease (MELD) score and mucosal-associated invariant T (MALT) cells counts and percentage (%). AUC: Area under the curve.

    B?ttcheret al[9]showed that MAIT cells were decreased in peripheral blood and liver tissue in autoimmune immune liver disease and found that intrahepatic MAIT cells tended to decrease with increasing fibrosis stage. They considered that the decrease was related to long-term exposure to cytokines and bacterial antigens, resulting in cell exhaustion. Together with their findings, our data showed a more significant decrease of circulating MAIT cells when the patients’ condition worsened. During the middle/late stage of liver failure, perhaps due to the long-term chronic course, circulating MAIT cells are increasingly depleted and the body mounts a dysfunctional immune response and enters an immunosuppressive state, resulting in viral persistence and aggravated conditions. Given that patients with end-stage chronic liver disease in most cases have at least some degree of malnutrition and decreased protein synthesis, maybe MAIT cells’ decrease is also associated with malnutrition, decreased protein synthesis and the reduction of lymphocytes.

    Previous research has suggested that successful antiviral therapy does not restore the frequency of circulating MAIT cells, such as in patients with CHB or HCV or human immunodeficiency virus infection. Bolte and Rehermann[6]once mentioned that HCV infection leaves a lasting imprint on the MAIT cell population. We discovered that after treatment, the frequency and number of circulating MAIT cells partially recovered when HBV-related liver failure improved. We believe that in different immune environments of diseases, the circulating MAIT cells may undergo different immune processes (including immune exhaustion and chronic immune activation), resulting in different function and behavior of MAIT cells in the systemic circulation. This was an important discovery, and it is worthy of further study to explore the mechanism in patients with HBV-related liver failure.

    Figure 7 Plasma levels of interleukin-12 and interleukin-18 were increased in patients with hepatitis B virus-related liver failure. A-D: Plasma level of interleukin (IL)-12p70 (A), IL-18 (B), IL-7 (C) and interferon-α (D) in healthy controls (HC) (n = 40) and patients with hepatitis B virus (HBV)-related liver failure (n = 46). aP < 0.05; dP < 0.0001. NS: No significance.

    Shenet al[31]have mentioned the lack of predictive prognostic biomarkers for hepatitis B virus-related acute-on-chronic liver failure (HBV-ACLF). Currently, the predictive scoring systems (including MELD and MELD-Na) for assessing the prognosis of patients with liver failure have defects, such as too complex, low sensitivity and limited application value. The prognosis of liver failure patients is poor. To find an objective, accurate and convenient prognostic marker for clinical application is still urgently needed. Given that the immune response plays a crucial role in the pathogenesis of liver failure, some immune-related prognostic markers appear, such as tumor necrosis factor-α-induced protein-8 like-2[33]. The latter is reported to have a potential role in predicting prognosis in patients with HBV-ACLF by negative regulation of cell-mediated immunity. Also, there were reports that peripheral myeloid-derived suppressor cells[34]and CD8 T cells acted as biomarkers for prognosis in HBV-ACLF. Our data indicate that circulating MAIT cells are an important marker for predicting the prognosis of HBV-related liver failure by showing obvious reduction of MAIT cells in deceased compared to surviving patients and a higher survival rate accompanied by higher expression of MAIT cells. It may be that depletion of MAIT cells leads to immunosuppression, increasing the risk of opportunistic infections, with severe consequences. Therefore, MAIT cells are vital for assessing the prognosis of patients with HBV-related liver failure, and early assessment can help physicians determine earlier which patients should receive liver transplantation and thus improve their prognosis.

    Previous studies have shown that the exhaustion of blood MAIT cells may be caused by inflammatory cytokines, including IL-12, IL-18, IFN-α and IL-7. To explore further the possible mechanism of MAIT cell reduction in HBV-related liver failure, we quantified the plasma level of IL-7, IL-12p70, IL-18 and IFN-α. The results showed that plasma levels of IL-12 and IL-18 were increased obviously in HBV-related liver failure. Zhanget al[35]concluded that, in parallel to the reduction of MAIT cells, the increase in IL-12 and IL-18 may contribute to MAIT cell activation, loss or death. We inferred that depletion of circulating MAIT cells might be caused by stimulation by IL-12 and IL-18 in HBV-related liver failure.

    In conclusion, circulating MAIT cells are decreased in HBV-related liver failure and associated with disease severity. Most importantly, circulating MAIT cells have a potential role in predicting prognosis in HBV-related liver failure patients. The mechanism of MAIT cell depletion needs to be further studied.

    ARTICLE HIGHLIGHTS

    Research background

    Immune responses play a crucial role in the pathogenesis of liver failure. Mucosalassociated invariant T (MAIT) cells are a novel population of innate-like lymphocytes involved in inflammatory liver disease, and their potential role in liver failure remains unclear.

    Research motivation

    To determine the role of circulating MAIT cells in patients with hepatitis B virus (HBV)-related liver failure and better understand the pathophysiological mechanism of liver failure, which is helpful for clinical decision-making.

    Research objectives

    This study aimed to explore the relationship between the alteration of circulating MAIT cells and prognosis of HBV-related liver failure.

    Research methods

    Fifty-five patients with HBV-related liver failure were enrolled to assess the effect of circulating MAIT cells. Peripheral blood mononuclear cells were isolated and the expression of circulating MAIT cells was detected by flow cytometry.

    Research results

    The level of circulating MAIT cells was reduced significantly in HBV-related liver failure patients. There was also a more significant reduction of MAIT cells in patients with HBV-related liver failure compared with chronic hepatitis B patients. The alteration of circulating MAIT cells is associated with the severity and prognosis of HBV-related liver failure.

    Research conclusions

    We conclude that the circulating MAIT cells may be an important prognostic marker for HBV-related liver failure, and the lower expression of circulating MAIT cells may indicate a poor prognosis.

    Research perspectives

    The circulating MAIT cells are vital for assessing the severity and prognosis of patients with HBV-related liver failure, and the mechanism of MAIT cell depletion needs to be further studied.

    ACKNOWLEDGEMENTS

    The authors would like to thank Nantong Third People’s Hospital Affiliated to Nantong University for their technical support.

    最新在线观看一区二区三区| 亚洲情色 制服丝袜| 黄色视频不卡| 精品久久久久久,| 亚洲成人免费电影在线观看| www日本在线高清视频| 欧美乱码精品一区二区三区| 人人澡人人妻人| 在线天堂中文资源库| 午夜影院日韩av| 久久精品国产综合久久久| 99久久精品国产亚洲精品| 天天添夜夜摸| 99re在线观看精品视频| 国产亚洲精品久久久久久毛片 | 久久香蕉精品热| 人人妻人人添人人爽欧美一区卜| 亚洲色图 男人天堂 中文字幕| 天堂中文最新版在线下载| 老汉色av国产亚洲站长工具| 成人特级黄色片久久久久久久| 中文字幕最新亚洲高清| 十分钟在线观看高清视频www| 精品国产一区二区三区久久久樱花| 丝袜在线中文字幕| 91在线观看av| 熟女少妇亚洲综合色aaa.| 如日韩欧美国产精品一区二区三区| 日韩欧美免费精品| 日韩欧美三级三区| 老熟女久久久| 国产高清国产精品国产三级| 国产成人欧美在线观看 | 高清在线国产一区| 亚洲黑人精品在线| 国产一区二区激情短视频| 国产蜜桃级精品一区二区三区 | 美女高潮喷水抽搐中文字幕| 精品国产亚洲在线| 看免费av毛片| 黄色片一级片一级黄色片| 欧美在线一区亚洲| 日韩欧美一区二区三区在线观看 | av片东京热男人的天堂| 午夜福利在线观看吧| 精品久久久久久久毛片微露脸| 两个人免费观看高清视频| 国产精品影院久久| 麻豆成人av在线观看| 两性午夜刺激爽爽歪歪视频在线观看 | 成人18禁高潮啪啪吃奶动态图| 欧美日韩福利视频一区二区| 五月开心婷婷网| 日韩成人在线观看一区二区三区| 日日夜夜操网爽| 免费久久久久久久精品成人欧美视频| 一个人免费在线观看的高清视频| 一本一本久久a久久精品综合妖精| 久久精品国产亚洲av香蕉五月 | 一二三四在线观看免费中文在| 777久久人妻少妇嫩草av网站| 国产精品一区二区在线不卡| 一进一出抽搐动态| 一边摸一边抽搐一进一小说 | 日韩欧美免费精品| 老汉色av国产亚洲站长工具| 午夜福利欧美成人| 女人爽到高潮嗷嗷叫在线视频| 国产精品一区二区在线不卡| 国产精品亚洲av一区麻豆| 国产熟女午夜一区二区三区| 俄罗斯特黄特色一大片| 99热只有精品国产| 久久亚洲精品不卡| 飞空精品影院首页| 欧美不卡视频在线免费观看 | 国产精品一区二区免费欧美| 久久午夜综合久久蜜桃| 女人爽到高潮嗷嗷叫在线视频| 中出人妻视频一区二区| 午夜免费成人在线视频| 国产精品一区二区在线观看99| 美女高潮到喷水免费观看| a级片在线免费高清观看视频| 又黄又爽又免费观看的视频| 久久国产亚洲av麻豆专区| 91精品国产国语对白视频| 无限看片的www在线观看| 激情在线观看视频在线高清 | 黄色视频不卡| 91成年电影在线观看| 欧美日韩亚洲综合一区二区三区_| 天堂中文最新版在线下载| 国产成人精品久久二区二区91| 交换朋友夫妻互换小说| 嫁个100分男人电影在线观看| 男人操女人黄网站| 在线观看午夜福利视频| 别揉我奶头~嗯~啊~动态视频| 99热网站在线观看| 午夜成年电影在线免费观看| 91老司机精品| 亚洲精品av麻豆狂野| 欧美久久黑人一区二区| 人人妻人人添人人爽欧美一区卜| 99精品在免费线老司机午夜| netflix在线观看网站| 精品久久久精品久久久| 下体分泌物呈黄色| 变态另类成人亚洲欧美熟女 | 久久久久国内视频| 亚洲九九香蕉| 国产成人影院久久av| 视频区图区小说| 欧美丝袜亚洲另类 | 啦啦啦 在线观看视频| 亚洲av日韩精品久久久久久密| 亚洲精品国产精品久久久不卡| 久久国产精品大桥未久av| 黄频高清免费视频| 天天添夜夜摸| 国产伦人伦偷精品视频| 一夜夜www| 欧美在线一区亚洲| 欧美成狂野欧美在线观看| 69精品国产乱码久久久| 亚洲精品乱久久久久久| 国产精品久久电影中文字幕 | 757午夜福利合集在线观看| 男男h啪啪无遮挡| 精品国内亚洲2022精品成人 | av天堂在线播放| 国产不卡一卡二| 宅男免费午夜| 美女高潮喷水抽搐中文字幕| 久久精品人人爽人人爽视色| 久久亚洲真实| 亚洲五月天丁香| 最新的欧美精品一区二区| 日本撒尿小便嘘嘘汇集6| 国产亚洲欧美精品永久| 亚洲精品国产色婷婷电影| 黑人猛操日本美女一级片| av天堂久久9| 人妻丰满熟妇av一区二区三区 | 新久久久久国产一级毛片| 人妻 亚洲 视频| videosex国产| 亚洲七黄色美女视频| 香蕉国产在线看| 夜夜夜夜夜久久久久| 欧美国产精品一级二级三级| 久久久久久久久免费视频了| 久久青草综合色| 国产在视频线精品| 日韩中文字幕欧美一区二区| av中文乱码字幕在线| 91麻豆精品激情在线观看国产 | 欧美老熟妇乱子伦牲交| 国产三级黄色录像| 满18在线观看网站| 一区在线观看完整版| 中文字幕色久视频| 精品一区二区三区av网在线观看| 一级毛片精品| 又黄又粗又硬又大视频| 下体分泌物呈黄色| 亚洲专区中文字幕在线| 一区福利在线观看| 黑丝袜美女国产一区| 黄网站色视频无遮挡免费观看| 九色亚洲精品在线播放| ponron亚洲| 国产主播在线观看一区二区| 久久香蕉国产精品| 电影成人av| 又大又爽又粗| 欧美另类亚洲清纯唯美| 免费一级毛片在线播放高清视频 | 成年人午夜在线观看视频| 又黄又爽又免费观看的视频| 国产精品成人在线| 亚洲成a人片在线一区二区| 最近最新中文字幕大全电影3 | 久久久久久久久久久久大奶| 免费在线观看黄色视频的| 狂野欧美激情性xxxx| 日日夜夜操网爽| av免费在线观看网站| 黄色 视频免费看| 免费黄频网站在线观看国产| 99热只有精品国产| 日韩视频一区二区在线观看| 久久精品成人免费网站| 老司机午夜十八禁免费视频| www.熟女人妻精品国产| 91精品国产国语对白视频| 欧美精品啪啪一区二区三区| 99在线人妻在线中文字幕 | 男女免费视频国产| 制服诱惑二区| 最新在线观看一区二区三区| www.精华液| 一级毛片高清免费大全| 侵犯人妻中文字幕一二三四区| av中文乱码字幕在线| 久久久国产精品麻豆| 成年人黄色毛片网站| 亚洲欧洲精品一区二区精品久久久| 久久久久视频综合| 欧美日韩亚洲国产一区二区在线观看 | 深夜精品福利| 最近最新免费中文字幕在线| 一进一出抽搐动态| 9色porny在线观看| 麻豆成人av在线观看| 天天影视国产精品| 午夜福利免费观看在线| 十八禁人妻一区二区| 国产高清videossex| 两性午夜刺激爽爽歪歪视频在线观看 | 精品福利永久在线观看| 亚洲第一欧美日韩一区二区三区| 9191精品国产免费久久| 国产99白浆流出| 少妇被粗大的猛进出69影院| 亚洲欧美一区二区三区黑人| 操美女的视频在线观看| 日日夜夜操网爽| 国产精品99久久99久久久不卡| 99re在线观看精品视频| 日韩三级视频一区二区三区| 国产亚洲精品久久久久5区| 中文字幕人妻熟女乱码| 国产人伦9x9x在线观看| 亚洲va日本ⅴa欧美va伊人久久| 日韩欧美国产一区二区入口| 国产欧美日韩精品亚洲av| 国产精品久久视频播放| 一级片'在线观看视频| 色婷婷久久久亚洲欧美| 国产在线一区二区三区精| 国产午夜精品久久久久久| 国产熟女午夜一区二区三区| 丰满迷人的少妇在线观看| 精品福利观看| 久久亚洲精品不卡| 亚洲黑人精品在线| 久久久久久亚洲精品国产蜜桃av| 亚洲成人手机| 老司机靠b影院| 国产91精品成人一区二区三区| 丝袜人妻中文字幕| 亚洲一卡2卡3卡4卡5卡精品中文| 国产激情久久老熟女| 国产精品久久久久成人av| 亚洲全国av大片| 亚洲,欧美精品.| 黄片大片在线免费观看| 日韩欧美在线二视频 | 女性生殖器流出的白浆| 亚洲人成电影免费在线| 欧美最黄视频在线播放免费 | 国产精品一区二区在线不卡| 老司机亚洲免费影院| 纯流量卡能插随身wifi吗| 天堂动漫精品| 欧美成狂野欧美在线观看| 久久久久精品国产欧美久久久| 黄网站色视频无遮挡免费观看| 高清欧美精品videossex| 热re99久久精品国产66热6| 国产精品香港三级国产av潘金莲| 精品免费久久久久久久清纯 | 老熟女久久久| 国产亚洲欧美在线一区二区| 成人手机av| 国产99久久九九免费精品| 少妇粗大呻吟视频| 精品乱码久久久久久99久播| 在线观看午夜福利视频| 美女扒开内裤让男人捅视频| 久久精品亚洲熟妇少妇任你| 日本五十路高清| 51午夜福利影视在线观看| 欧美一级毛片孕妇| 欧美日韩国产mv在线观看视频| 午夜视频精品福利| 色94色欧美一区二区| 免费不卡黄色视频| 久久国产亚洲av麻豆专区| 欧美成人午夜精品| 久久精品aⅴ一区二区三区四区| 高清黄色对白视频在线免费看| 熟女少妇亚洲综合色aaa.| 亚洲色图av天堂| 久久久精品免费免费高清| 电影成人av| 夫妻午夜视频| 日韩中文字幕欧美一区二区| 欧美激情 高清一区二区三区| 欧美精品人与动牲交sv欧美| 多毛熟女@视频| 精品福利观看| 欧美黑人精品巨大| 色精品久久人妻99蜜桃| 最近最新中文字幕大全电影3 | 黄色毛片三级朝国网站| 国产精品久久久久久精品古装| av有码第一页| 免费观看a级毛片全部| 亚洲 欧美一区二区三区| 国产无遮挡羞羞视频在线观看| www.999成人在线观看| 亚洲五月婷婷丁香| 久久热在线av| 久久久久久免费高清国产稀缺| 亚洲第一青青草原| 一级,二级,三级黄色视频| 欧美久久黑人一区二区| 国产亚洲av高清不卡| 久久精品aⅴ一区二区三区四区| 老鸭窝网址在线观看| 国产精品永久免费网站| 少妇 在线观看| 热99久久久久精品小说推荐| 久久亚洲真实| 久久久久视频综合| 精品福利观看| 亚洲精品久久成人aⅴ小说| 亚洲欧美一区二区三区黑人| 久久这里只有精品19| 美女扒开内裤让男人捅视频| av不卡在线播放| 亚洲精品久久成人aⅴ小说| 亚洲国产精品一区二区三区在线| 亚洲精品自拍成人| 久久人人爽av亚洲精品天堂| 在线十欧美十亚洲十日本专区| 亚洲国产精品sss在线观看 | 亚洲熟妇中文字幕五十中出 | 如日韩欧美国产精品一区二区三区| 免费av中文字幕在线| 久久久精品区二区三区| 欧美激情极品国产一区二区三区| 国产成人av教育| 精品国产国语对白av| 免费少妇av软件| 一区二区三区精品91| 国产成+人综合+亚洲专区| 纯流量卡能插随身wifi吗| 国产精品免费一区二区三区在线 | 两个人看的免费小视频| 日本黄色视频三级网站网址 | 在线观看舔阴道视频| 国产野战对白在线观看| 久久精品成人免费网站| 免费在线观看日本一区| 男女午夜视频在线观看| 亚洲黑人精品在线| 亚洲欧美日韩高清在线视频| 丝瓜视频免费看黄片| 中文字幕另类日韩欧美亚洲嫩草| 欧美日韩亚洲国产一区二区在线观看 | 欧美人与性动交α欧美软件| 久久精品国产清高在天天线| 欧美乱妇无乱码| 免费一级毛片在线播放高清视频 | 最新在线观看一区二区三区| 国产精品一区二区精品视频观看| 高清视频免费观看一区二区| 国产欧美日韩一区二区精品| 久久精品国产综合久久久| 久久国产精品男人的天堂亚洲| 啪啪无遮挡十八禁网站| 精品欧美一区二区三区在线| 又紧又爽又黄一区二区| 91精品三级在线观看| 亚洲人成伊人成综合网2020| 久久久久国产精品人妻aⅴ院 | 老司机福利观看| 精品国产超薄肉色丝袜足j| 午夜福利免费观看在线| 欧美日韩亚洲国产一区二区在线观看 | 一本综合久久免费| 国产不卡av网站在线观看| 国产精品美女特级片免费视频播放器 | 国产成+人综合+亚洲专区| 他把我摸到了高潮在线观看| 黄色片一级片一级黄色片| 香蕉久久夜色| 一区福利在线观看| 亚洲五月婷婷丁香| 久久精品亚洲精品国产色婷小说| 少妇被粗大的猛进出69影院| 午夜精品久久久久久毛片777| 91九色精品人成在线观看| 欧美黑人精品巨大| 女警被强在线播放| 午夜激情av网站| 久久香蕉国产精品| 精品欧美一区二区三区在线| 亚洲三区欧美一区| 日韩视频一区二区在线观看| 欧美国产精品一级二级三级| 欧美日韩黄片免| 少妇裸体淫交视频免费看高清 | 精品一区二区三卡| 大香蕉久久成人网| 一本大道久久a久久精品| 黄片小视频在线播放| 欧美丝袜亚洲另类 | 久久草成人影院| 大型黄色视频在线免费观看| 视频在线观看一区二区三区| 国产成人精品久久二区二区免费| 国产av一区二区精品久久| 99精品久久久久人妻精品| 欧美性长视频在线观看| 亚洲av美国av| 女人被狂操c到高潮| 久热爱精品视频在线9| 国产一区二区激情短视频| 欧美日韩亚洲国产一区二区在线观看 | netflix在线观看网站| 精品人妻在线不人妻| 亚洲人成电影观看| 精品久久久精品久久久| 少妇被粗大的猛进出69影院| 女警被强在线播放| 在线观看免费视频日本深夜| 亚洲中文av在线| 国产xxxxx性猛交| 久热这里只有精品99| 亚洲精品自拍成人| 国产片内射在线| 精品亚洲成a人片在线观看| 99国产综合亚洲精品| 免费av中文字幕在线| 在线观看一区二区三区激情| 俄罗斯特黄特色一大片| 女人被狂操c到高潮| 黄色 视频免费看| 国产精品久久视频播放| 中文字幕高清在线视频| 日韩 欧美 亚洲 中文字幕| 黄色片一级片一级黄色片| 建设人人有责人人尽责人人享有的| 精品久久久久久久毛片微露脸| 国产片内射在线| 国产又色又爽无遮挡免费看| x7x7x7水蜜桃| 又紧又爽又黄一区二区| 99精国产麻豆久久婷婷| 精品久久久久久久久久免费视频 | 人人妻人人添人人爽欧美一区卜| 村上凉子中文字幕在线| 后天国语完整版免费观看| 水蜜桃什么品种好| 51午夜福利影视在线观看| 午夜日韩欧美国产| 人妻一区二区av| 美女扒开内裤让男人捅视频| 亚洲伊人色综图| 午夜精品在线福利| av不卡在线播放| 人人妻人人澡人人爽人人夜夜| 亚洲在线自拍视频| 日韩欧美一区视频在线观看| 视频区图区小说| 动漫黄色视频在线观看| 亚洲精品自拍成人| 又黄又爽又免费观看的视频| 国产成人精品在线电影| 久久久久久久久免费视频了| 国产蜜桃级精品一区二区三区 | 亚洲少妇的诱惑av| 99香蕉大伊视频| 一区二区三区激情视频| a级毛片在线看网站| 手机成人av网站| 久久中文字幕一级| 亚洲色图综合在线观看| 黄色女人牲交| 操美女的视频在线观看| 12—13女人毛片做爰片一| 这个男人来自地球电影免费观看| 亚洲国产精品合色在线| 国产av精品麻豆| 看片在线看免费视频| 成年人免费黄色播放视频| av网站在线播放免费| 国产成人系列免费观看| 国产精品秋霞免费鲁丝片| 老汉色∧v一级毛片| 日韩大码丰满熟妇| 老司机在亚洲福利影院| 成人亚洲精品一区在线观看| 日日夜夜操网爽| 国产欧美日韩精品亚洲av| 人人澡人人妻人| 国产欧美日韩一区二区三| 大片电影免费在线观看免费| 波多野结衣av一区二区av| 99久久精品国产亚洲精品| 日韩免费av在线播放| 制服诱惑二区| 精品国产超薄肉色丝袜足j| 中亚洲国语对白在线视频| 一级黄色大片毛片| av超薄肉色丝袜交足视频| 手机成人av网站| 中亚洲国语对白在线视频| 一级黄色大片毛片| 久久精品91无色码中文字幕| 欧美国产精品va在线观看不卡| 叶爱在线成人免费视频播放| 在线观看舔阴道视频| 欧美日韩乱码在线| 咕卡用的链子| 欧美日韩亚洲综合一区二区三区_| 热re99久久国产66热| 亚洲第一青青草原| 国产高清国产精品国产三级| 日韩欧美一区视频在线观看| √禁漫天堂资源中文www| 日韩欧美一区二区三区在线观看 | 国产在视频线精品| 香蕉丝袜av| 无限看片的www在线观看| 亚洲九九香蕉| 在线观看舔阴道视频| 久久中文字幕人妻熟女| 韩国av一区二区三区四区| 亚洲av电影在线进入| 亚洲国产欧美网| 亚洲人成77777在线视频| 亚洲欧美一区二区三区久久| 久久香蕉国产精品| 少妇猛男粗大的猛烈进出视频| 黄片小视频在线播放| 欧美久久黑人一区二区| 天堂动漫精品| 丁香六月欧美| 岛国毛片在线播放| 一级毛片高清免费大全| 精品久久久久久久毛片微露脸| 国产成人精品久久二区二区免费| 亚洲中文av在线| 欧美中文综合在线视频| 美女午夜性视频免费| 夫妻午夜视频| 亚洲视频免费观看视频| 最新美女视频免费是黄的| 在线永久观看黄色视频| 亚洲精品乱久久久久久| 久久狼人影院| 国产区一区二久久| 中文字幕制服av| 国产成人免费观看mmmm| 久久久国产欧美日韩av| 亚洲第一欧美日韩一区二区三区| 搡老岳熟女国产| 国产成人啪精品午夜网站| 久热这里只有精品99| 国产亚洲欧美精品永久| 欧美+亚洲+日韩+国产| 青草久久国产| 亚洲国产欧美日韩在线播放| 亚洲aⅴ乱码一区二区在线播放 | x7x7x7水蜜桃| 在线视频色国产色| e午夜精品久久久久久久| 精品国产一区二区三区四区第35| 国产成人免费观看mmmm| 午夜影院日韩av| 久久精品国产99精品国产亚洲性色 | 国产真人三级小视频在线观看| 777米奇影视久久| 亚洲片人在线观看| 黄色丝袜av网址大全| 人妻一区二区av| av国产精品久久久久影院| 亚洲男人天堂网一区| 国产aⅴ精品一区二区三区波| 美女高潮喷水抽搐中文字幕| 免费一级毛片在线播放高清视频 | av免费在线观看网站| 黄片大片在线免费观看| 丰满饥渴人妻一区二区三| 亚洲一卡2卡3卡4卡5卡精品中文| 久久精品国产a三级三级三级| 久久久久久亚洲精品国产蜜桃av| 国产淫语在线视频| 成人影院久久| 亚洲久久久国产精品| 一区二区三区国产精品乱码| 狠狠婷婷综合久久久久久88av| 下体分泌物呈黄色| 18禁裸乳无遮挡免费网站照片 | 午夜两性在线视频| 久久性视频一级片| 男人舔女人的私密视频| 成人国语在线视频| 免费少妇av软件| 大码成人一级视频| 欧美亚洲日本最大视频资源| 亚洲国产欧美一区二区综合| 亚洲国产精品合色在线| 老鸭窝网址在线观看| 激情视频va一区二区三区| 黄色片一级片一级黄色片| 丁香欧美五月| 久久人妻av系列| 女人久久www免费人成看片|